Study evaluating preference, satisfaction and ease of use of inhalers in COPD diagnosed patients

Completed

• Conditions: chronic obstructive lung disease; smokers lung; 10038716

• Registration Number: NL-OMON35964
• Lead Sponsor: Almirall

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

male or female aged > 39 years
stable COPD
naïve to the study inhalers

Exclusion Criteria

clinical significant disease, particular body malformations of diseases affecting coordination and/or motor system (e.g. malformations or lack of upper extremities, Any disease that may affect the proper handling of the inhalers (Wilson*s disease, Stroke, Parkinson, Huntington*s Chorea...) ;unable to read product package instructions and to answer questionnaires

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary variable is the percentage of patients who prefer the new inhaler<br /><br>at visit 2.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secundary outcome<br /><br>ease of use<br /><br>convenience<br /><br>ease of learning to use<br /><br>ease of holding<br /><br>ease of operating<br /><br>ease of preparation of the dose<br /><br>feedback to indicate correct inhalation<br /><br>dosage</p><br>